“…These abnormalities are likely to be caused by neural crest (NC) developmental defects, indicating that BOFS is a human neurocristopathy (Trainor, 2015). In agreement with this, all BOFS patients reported to date carry heterozygous mutations or deletions within TFAP2A that are predicted to result in either antimorphic, hypomorphic, or null alleles for this NC master regulator (Brewer et al, 2004;LeBlanc et al, 2013;Li et al, 2013;Milunsky et al, 2008Milunsky et al, , 2011. Furthermore, although Tfap2a-null mice display a BOFS-like phenotype, Tfap2a +/À animals appear morphologically normal and, thus, are not haploinsufficient (Brewer et al, 2004;Schorle et al, 1996;Zhang et al, 1996), highlighting the need to ideally investigate BOFS in a human embryonic context.…”